Armata Pharmaceuticals
ARMP
ARMP
23 hedge funds and large institutions have $2.57M invested in Armata Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $22K
Holders
23
Holding in Top 10
–
Calls
–
Puts
$22K
Top Buyers
| 1 | +$37K | |
| 2 | +$16.3K | |
| 3 | +$7.32K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.42K |
| 5 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$132 |
Top Sellers
| 1 | -$18.5K | |
| 2 | -$16.1K | |
| 3 | -$11.5K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$10.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$513 |